Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

OTIC

Otonomy (OTIC)

Otonomy Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OTIC
DateTimeSourceHeadlineSymbolCompany
11/25/20152:27PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OTICOtonomy Inc
11/24/20157:00AMGlobeNewswire Inc.Otonomy to Present at Piper Jaffray Healthcare ConferenceNASDAQ:OTICOtonomy Inc
11/18/20157:00AMGlobeNewswire Inc.Otonomy Initiates Patient Enrollment in U.S. Phase 3 Clinical Trial of OTO-104 in Meniere's DiseaseNASDAQ:OTICOtonomy Inc
11/16/20157:30AMGlobeNewswire Inc.Otonomy Initiates Phase 1 Clinical Trial for Tinnitus Product Candidate, OTO-311NASDAQ:OTICOtonomy Inc
11/10/20154:21PMGlobeNewswire Inc.Otonomy Reports Third Quarter 2015 Financial Results and Provides Corporate UpdateNASDAQ:OTICOtonomy Inc
11/10/20154:12PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OTICOtonomy Inc
11/10/20154:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OTICOtonomy Inc
11/03/20157:30AMGlobeNewswire Inc.Otonomy Initiates Open-Label Clinical Trial for OTIPRIO(TM) in Pediatric Patients With History of Otitis Media Requiring Tymp...NASDAQ:OTICOtonomy Inc
10/09/20154:48PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OTICOtonomy Inc
10/07/20158:00AMGlobeNewswire Inc.Otonomy Holds Investor and Analyst Day and Provides Corporate UpdateNASDAQ:OTICOtonomy Inc
10/05/20157:30AMGlobeNewswire Inc.Otonomy Receives FDA Clearance of Investigational New Drug Application for Tinnitus Product Candidate, OTO-311NASDAQ:OTICOtonomy Inc
09/30/20157:30AMGlobeNewswire Inc.Otonomy to Host Investor and Analyst Day on October 7, 2015NASDAQ:OTICOtonomy Inc
09/24/20157:30AMGlobeNewswire Inc.Otonomy to Present Results for AuriPro(TM) Phase 3 and OTO-104 Phase 2b Clinical Trials at 2015 AAO-HNSF Annual MeetingNASDAQ:OTICOtonomy Inc
09/22/20157:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OTICOtonomy Inc
09/21/20158:46PMGlobeNewswire Inc.Otonomy Announces Successful End-of-Phase 2 Meeting With the FDA for OTO-104 in Meniere's DiseaseNASDAQ:OTICOtonomy Inc
09/18/20157:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OTICOtonomy Inc
09/16/20155:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OTICOtonomy Inc
09/16/20159:30AMPR Newswire (US)Quarterly Results and Business Updates - Report on OtonomyNASDAQ:OTICOtonomy Inc
09/15/20155:51PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OTICOtonomy Inc
09/15/20156:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:OTICOtonomy Inc
09/04/20154:03PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:OTICOtonomy Inc
09/03/20154:16PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:OTICOtonomy Inc
09/01/20155:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OTICOtonomy Inc
09/01/20155:24PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OTICOtonomy Inc
09/01/20154:15PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OTICOtonomy Inc
08/12/20154:16PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OTICOtonomy Inc
08/12/20154:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OTICOtonomy Inc
08/10/20154:37PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OTICOtonomy Inc
08/07/20159:09AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OTICOtonomy Inc
07/10/201512:24PMEdgar (US Regulatory)Schedule 13g
(sc 13g)
NASDAQ:OTICOtonomy Inc
 Showing the most relevant articles for your search:NASDAQ:OTIC